Showing 701-710 of 951 results for "".
Cannabinoids and the Endocannabinoid System: Emerging Trends
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-the-endocannabinoid-system-emerging-trends/30406/Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.Parkinson's Pathology: Elucidating the Role of LRRK2
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-pathology-elucidating-the-role-of-lrrk2/30475/Playing a critical role in Parkinson's disease, LRRK2 offers a potential path toward better understanding and potentially treating the condition.Concussion Management: What to Know Now
https://practicalneurology.com/diseases-diagnoses/tbi/concussion-management-what-to-know-now/30538/A specialist provides a comprehensive overview of the management of post-concussion symptoms.Dementia Insights: Cognitive Impairment In Primary Psychiatric Disorders: Role In The Diagnosis Of Cognitive Disorders In Clinical Neurology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-cognitive-impairment-in-primary-psychiatric-disorders-role-in-the-diagnosis-of-cognitive-disorders-in-clinical-neurology/30746/How does the presence of an ongoing primary psychiatric disorder with or without pharmacotherapy play a role in our aging population who present to the neurologist with symptoms of memory loss and cognitive decline?Cardiac Cephalgia
https://practicalneurology.com/diseases-diagnoses/headache-pain/cardiac-cephalgia/31657/Some cardiac workup is a necessary part of headache evaluation to assess for secondary headache and potential risks of available headache treatments.Special Report: 2024 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-2024-neurology-drug-device-approvals/33149/A quick reference for the drugs and devices for neurologic conditions that received approval or clearance notice from the Food and Drug Administration (FDA) last year.Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/headache-pain/chronic-inflammatory-demyelinating-polyneuropathy/31813/Updates in diagnosis and management.Don't Wait: Rethinking Parkinson's Disease Care for Brain Health
https://practicalneurology.com/diseases-diagnoses/movement-disorders/dont-wait-rethinking-parkinsons-disease-care-for-brain-health/36533/A holistic, brain-health-first approach and access to innovative treatments can give patients more than hope. It can give them back their time.Emerging Anticoagulation Therapies: A Key “Factor” in Secondary Stroke Prevention Following an Ischemic Stroke?
https://practicalneurology.com/diseases-diagnoses/stroke/emerging-anticoagulation-therapies-a-key-factor-in-secondary-stroke-prevention-following-an-ischemic-stroke/35761/Quality of Life for Older People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/quality-of-life-for-older-people-with-epilepsy/32178/Focusing on all aspects of health and well-being when treating older adults with epilepsy is important for improving quality of life.